132 related articles for article (PubMed ID: 34446801)
1. Non-toxic polymer nanovectors for improved delivery of dexamethasone.
Ede BC; Diamanti P; Williams DS; Blair A
Sci Rep; 2021 Aug; 11(1):17263. PubMed ID: 34446801
[TBL] [Abstract][Full Text] [Related]
2. Antitumor efficacy of dexamethasone-loaded core-crosslinked polymeric micelles.
Coimbra M; Rijcken CJ; Stigter M; Hennink WE; Storm G; Schiffelers RM
J Control Release; 2012 Nov; 163(3):361-7. PubMed ID: 23041274
[TBL] [Abstract][Full Text] [Related]
3. Novel controlled drug release system engineered with inclusion complexes based on carboxylic graphene.
Xiao Y; Zhang M; Fan Y; Zhang Q; Wang Y; Yuan W; Zhou N; Che J
Colloids Surf B Biointerfaces; 2019 Mar; 175():18-25. PubMed ID: 30513470
[TBL] [Abstract][Full Text] [Related]
4. ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia.
Peirs S; Matthijssens F; Goossens S; Van de Walle I; Ruggero K; de Bock CE; Degryse S; Canté-Barrett K; Briot D; Clappier E; Lammens T; De Moerloose B; Benoit Y; Poppe B; Meijerink JP; Cools J; Soulier J; Rabbitts TH; Taghon T; Speleman F; Van Vlierberghe P
Blood; 2014 Dec; 124(25):3738-47. PubMed ID: 25301704
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial release of dexamethasone and amiodarone from a nano-structured parylene-C film to reduce perioperative inflammation and atrial fibrillation.
Robinson E; Kaushal S; Alaboson J; Sharma S; Belagodu A; Watkins C; Walker B; Webster G; McCarthy P; Ho D
Nanoscale; 2016 Feb; 8(7):4267-75. PubMed ID: 26838117
[TBL] [Abstract][Full Text] [Related]
6. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
Kim DH; Martin DC
Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor.
Bachmann PS; Gorman R; Mackenzie KL; Lutze-Mann L; Lock RB
Blood; 2005 Mar; 105(6):2519-26. PubMed ID: 15572593
[TBL] [Abstract][Full Text] [Related]
8. Polymeric delivery systems for dexamethasone.
Urbańska J; Karewicz A; Nowakowska M
Life Sci; 2014 Feb; 96(1-2):1-6. PubMed ID: 24373835
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine.
Krishnan V; Xu X; Barwe SP; Yang X; Czymmek K; Waldman SA; Mason RW; Jia X; Rajasekaran AK
Mol Pharm; 2013 Jun; 10(6):2199-210. PubMed ID: 23194373
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia.
Caracciolo D; Riillo C; Ballerini A; Gaipa G; Lhermitte L; Rossi M; Botta C; Duroyon E; Grillone K; Gallo Cantafio ME; Buracchi C; Alampi G; Gulino A; Belmonte B; Conforti F; Golino G; Juli G; Altomare E; Polerà N; Scionti F; Arbitrio M; Iannone M; Martino M; Correale P; Talarico G; Ghelli Luserna di Rorà A; Ferrari A; Concolino D; Sestito S; Pensabene L; Giordano A; Hildinger M; Di Martino MT; Martinelli G; Tripodo C; Asnafi V; Biondi A; Tagliaferri P; Tassone P
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33597219
[TBL] [Abstract][Full Text] [Related]
11. Polymer-free corticosteroid dimer implants for controlled and sustained drug delivery.
Battiston K; Parrag I; Statham M; Louka D; Fischer H; Mackey G; Daley A; Gu F; Baldwin E; Yang B; Muirhead B; Hicks EA; Sheardown H; Kalachev L; Crean C; Edelman J; Santerre JP; Naimark W
Nat Commun; 2021 May; 12(1):2875. PubMed ID: 34001908
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts.
Szymanska B; Wilczynska-Kalak U; Kang MH; Liem NL; Carol H; Boehm I; Groepper D; Reynolds CP; Stewart CF; Lock RB
PLoS One; 2012; 7(3):e33894. PubMed ID: 22479469
[TBL] [Abstract][Full Text] [Related]
13. Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo.
Kroon J; Buijs JT; van der Horst G; Cheung H; van der Mark M; van Bloois L; Rizzo LY; Lammers T; Pelger RC; Storm G; van der Pluijm G; Metselaar JM
Prostate; 2015 Jun; 75(8):815-24. PubMed ID: 25663076
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis.
Wang Q; Jiang J; Chen W; Jiang H; Zhang Z; Sun X
J Control Release; 2016 May; 230():64-72. PubMed ID: 27057749
[TBL] [Abstract][Full Text] [Related]
15. Harnessing the Noncovalent Interactions of DNA Backbone with 2D Silicate Nanodisks To Fabricate Injectable Therapeutic Hydrogels.
Basu S; Pacelli S; Feng Y; Lu Q; Wang J; Paul A
ACS Nano; 2018 Oct; 12(10):9866-9880. PubMed ID: 30189128
[TBL] [Abstract][Full Text] [Related]
16. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
[TBL] [Abstract][Full Text] [Related]
17. OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL.
Evans K; Duan J; Pritchard T; Jones CD; McDermott L; Gu Z; Toscan CE; El-Zein N; Mayoh C; Erickson SW; Guo Y; Meng F; Jung D; Rathi KS; Roberts KG; Mullighan CG; Shia CS; Pearce T; Teicher BA; Smith MA; Lock RB
Clin Cancer Res; 2019 Jul; 25(14):4493-4503. PubMed ID: 31015346
[TBL] [Abstract][Full Text] [Related]
18. Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery.
Yu A; Shi H; Liu H; Bao Z; Dai M; Lin D; Lin D; Xu X; Li X; Wang Y
Int J Pharm; 2020 Feb; 575():118943. PubMed ID: 31830575
[TBL] [Abstract][Full Text] [Related]
19. Drug-loaded carbon nanohorns: adsorption and release of dexamethasone in vitro.
Murakami T; Ajima K; Miyawaki J; Yudasaka M; Iijima S; Shiba K
Mol Pharm; 2004; 1(6):399-405. PubMed ID: 16028351
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable, Drug-Loaded Nanovectors via Direct Hydration as a New Platform for Cancer Therapeutics.
Ridolfo R; Ede BC; Diamanti P; White PB; Perriman AW; van Hest JCM; Blair A; Williams DS
Small; 2018 Aug; 14(32):e1703774. PubMed ID: 29999236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
